A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

By J. Mohr, John L.P. Thompson, Ronald M. Lazar, B. Levin, R. Sacco, K. Furie, J. Kistler, G. Albers, L. Pettigrew, H. Adams and 2 more. New England Journal of Medicine, 2001

1,149 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/c96c0df6dce9f868be22bab88c03a40efc2ab9f7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. I. Graham
2. Hani Jneid
3. Alberico L. Catapano

In Pulmonary and Respiratory Medicine

1. I. Graham
2. T. Ivanova

Citations in the corpus

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, neutral): “are not superior to aspirin and are associatedwith a higher bleeding risk [468, 469].”
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “In such patients, oral vitamin K antagonists are not superior to aspirin and are associated with a higher bleeding risk.(468,469)”
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “In such patients oral vitamin K antagonists are not superior to aspirin but are associated with a higher bleeding risk.(512,513)”